Cervical Cancer Screening Market to Reach USD 16.8 Billion by 2031,...

Autres

Cervical Cancer Screening Market to Reach USD 16.8 Billion by 2031, Driven by HPV Testing and AI-Enhanced Cytology

2025-06-20 13:20:53 • Visualizações

[Geneva, 20 June 2025] – The global cervical cancer screening market is projected to grow from USD 10.12 billion in 2024 to USD 16.84 billion by 2031, with a CAGR of 7.5%, according to Clearview Market Insights (CVMI).

“With HPV DNA tests offering better sensitivity and AI-based cytology improving diagnostic efficiency, countries are moving rapidly toward scalable, quality screening,” said Dr. Serena Bianchi, CVMI’s Director of Oncology Diagnostics.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-cervical-cancer-screening-market/

Growth Highlights:

HPV DNA test adoption increasing in North America, Europe, and select APAC markets
Self-sampling kits and mobile screening vans enhancing rural access
Hologic, Roche, and Qiagen driving innovation in diagnostics automation
WHO programs backing cervical cancer elimination efforts in 85+ nations

Segment Insights:

HPV DNA screening is now replacing Pap smear tests and comprises over 42% of the market share. While VIA testing continues in rural outreach programs, it faces limitations in sensitivity and standardization.

Regional Outlook:

Europe and North America are at the forefront of AI-enabled cytology and co-testing. The Asia-Pacific region is advancing rapidly, bolstered by India’s National Cervical Cancer Elimination Plan and China’s 2024 HPV DNA subsidy. Latin America and Sub-Saharan Africa are implementing hybrid models that combine self-sampling with mobile labs.

Innovation Watch:

Hologic’s Genius Digital Diagnostics system improves AI-slide triage
Qiagen expands rapid HPV kits for field testing
Roche deploys CINtec with p16/Ki-67 markers in multi-country trials

Outlook to 2031:
By 2031, more than 60% of global screenings will transition to molecular-based platforms. The integration of home-based kits and mobile diagnostics will increase LMIC coverage to over 50%, moving the world closer to WHO’s vision of elimination.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

Faça Login para curtir, compartilhar e comentar!

Cervical Cancer Screening Market to Reach USD 16.8 Billion by 2031, Driven by HPV Testing and AI-Enhanced Cytology

Optical Waveguide Market Size: Industry Analysis, Share, Segmentation, Price Trends, Regional Analysis and Forecast 2024-2032

Regenerative Medicine Market Size to Reach USD 177.9 Billion by 2030 | SNS Insider

Germany Spinning Machinery Market Share and Growth Insights, Forecast 2032

Participar

Idiomas

Cervical Cancer Screening Market to Reach USD 16.8 Billion by 2031, Driven by HPV Testing and AI-Enhanced Cytology

Optical Waveguide Market Size: Industry Analysis, Share, Segmentation, Price Trends, Regional Analysis and Forecast 2024-2032

Regenerative Medicine Market Size to Reach USD 177.9 Billion by 2030 | SNS Insider

Germany Spinning Machinery Market Share and Growth Insights, Forecast 2032